Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, One Year, Non-Comparative Study To Evaluate The Safety And Tolerability Of Intravitreous Pegaptanib Sodium In Patients With Diabetic Macular Edema

NCT01189461 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01189461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01189461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, One Year, Non-Comparative Study To Evaluate The Safety And Tolerability Of Intravitreous Pegaptanib Sodium In Patients With Diabetic Macular Edema
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2011
Completion date
July 31, 2012
Enrollment
46 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

anti- vgf inhibitor, diabetic macular edema, diabetic retinopathy